Innovent Biologics Eulerpool naujienos

Innovent Biologics Eulerpool News

Innovent Biologics akcijų naujienos

Innovent Biologics stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Innovent Biologics naujienas mes pateikiame čia.

• rugsėjo 11 d. ·

  Yahoo
  Innovent Delivers Oral Presentation on Phase 1 Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer at the 2024 WCLC
• rugsėjo 10 d. ·

  Yahoo
  Innovent Delivers Oral Presentation of Updated Results from a Pivotal Phase 2 Study of Dupert® (Fulzerasib) in Patients with Advanced Non-Small Cell Lung Cancer Harboring KRAS G12C Mutation
• rugsėjo 9 d. ·

  Yahoo
  High Growth Tech Stocks to Watch in Hong Kong September 2024
• rugsėjo 9 d. ·

  Yahoo
  SEHK Value Picks That Could Be Undervalued In September 2024
• rugsėjo 9 d. ·

  Yahoo
  High Growth Tech Stocks In Hong Kong Featuring 3 Prominent Picks
• rugsėjo 4 d. ·

  Yahoo
  FDA grants fast track status to Innovent’s IBI363 for melanoma
• rugsėjo 4 d. ·

  Yahoo
  Innovent Receives Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α Bispecific Antibody Fusion Protein) as Monotherapy for Advanced Melanoma
• rugsėjo 2 d. ·

  Yahoo
  Innovent Annouces Multiple Clinical Study Results of Mazdutide to be Presented at the EASD 2024
• rugpjūčio 29 d. ·

  Yahoo
  Innovent to Present Clinical Data of Multiple Novel Molecules at WCLC and ESMO 2024
• rugpjūčio 28 d. ·

  Yahoo
  Innovent Announces 2024 Interim Results and Business Updates